Anhui Anke Biotechnology (Group) Co., Ltd.

¥8.01As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300009Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 0.87%
Div yield 3.12%
ROE 15.10%
Biotechnology
Beta (5Y) 0.43
PE TTM 20.54
TSR TTM (24.28%)
Mkt cap ¥13.35B
ROIC 20.46%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥9.85
23.01%
(67.56%)
Hold 3|6|10|5|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.12
0.13
0.13
0.12
18.43%
12.96%
9.36%
4.23%
Revenue¥M
831.9
826.0
864.9
853.5
13.53%
8.07%
13.96%
6.23%
Peers (US$2.002B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
4.079
(0.345)
(0.276)
EBIT/Intx
0.966
0.238
0.230
Own earn%
(92.92)
(75.98)
(61.98)
Sh yield%
31.64
53.74
52.51
Owners
Insiders/Inst%
3.44
71.08
Short interest%
2.33
SBC / revenue%
5.65
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
7–15
$1 testx
0.0
Incr. ROIC%
0